{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:25:18Z","timestamp":1769106318126,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Vifor France"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The diagnosis and treatment of iron deficiency is a primary public health goal. This study aimed to make an inventory of the use of biomarkers to assess the iron supply in patients given iron replacement therapy. A retrospective longitudinal real-world study of a cohort of patients receiving iron replacement therapy was conducted using data from healthcare coverage databases between January 2006 and December 2015 in France. The frequency of oral or intravenous iron treatment episodes preceded and\/or followed by a biological assessment of iron deficiency was described. We then differentiate patients with or without chronic inflammatory diseases, which could impact the prescription. The evolution between 2006 and 2015 was also studied. The 96,724 patients received an average of 4.9 administrations of iron per patient, corresponding to 1.7 treatment episodes. In one-third of treatment episodes (34.6%), patients had a pre-treatment biological assessment, 15.5% a post-treatment assessment, and 7.3% both. The post-treatment measure of iron supply markers (i.e., Ferritin and transferrin saturation) was more frequent in patients suffering from chronic inflammatory diseases than in those without underlying chronic condition (22.6% to 41.0% vs. 3.1%; p\u2009&lt;\u20090.0001). Serum ferritin was measured 30 times more than transferrin saturation measurements. The use of both tests increased steadily during the study period, although remaining low. Despite the recommendations, biological assessments of iron status are seldom prescribed and\/or performed in the context of a pre- or post-treatment assessment, although more frequently realized in patients with chronic inflammatory diseases.<\/jats:p>","DOI":"10.1038\/s41598-020-72057-9","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T10:09:21Z","timestamp":1599818961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Iron deficiency markers in patients undergoing iron replacement therapy: a 9-year retrospective real-world evidence study using healthcare databases"],"prefix":"10.1038","volume":"10","author":[{"given":"Patrice","family":"Cacoub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gael","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katell","family":"Peoc\u2019h","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"key":"72057_CR1","unstructured":"World Health Organisation. Carences En Micronutriments. https:\/\/www.who.int\/nutrition\/topics\/ida\/fr\/."},{"key":"72057_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1182\/blood-2018-05-815944","volume":"133","author":"C Camaschella","year":"2019","unstructured":"Camaschella, C. Iron deficiency. Blood 133, 30\u201339 (2019).","journal-title":"Blood"},{"key":"72057_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","volume":"142","author":"MW Hentze","year":"2010","unstructured":"Hentze, M. W., Muckenthaler, M. U., Galy, B. & Camaschella, C. Two to tango: regulation of Mammalian iron metabolism. Cell 142, 24\u201338 (2010).","journal-title":"Cell"},{"key":"72057_CR4","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1017\/S0007114517001349","volume":"117","author":"K Yokoi","year":"2017","unstructured":"Yokoi, K. & Konomi, A. Iron deficiency without anaemia is a potential cause of fatigue: meta-analyses of randomised controlled trials and cross-sectional studies. Br. J. Nutr. 117, 1422\u20131431 (2017).","journal-title":"Br. J. Nutr."},{"key":"72057_CR5","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3945\/ajcn.114.103366","volume":"102","author":"L Peyrin-Biroulet","year":"2015","unstructured":"Peyrin-Biroulet, L., Williet, N. & Cacoub, P. Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review. Am. J. Clin. Nutr. 102, 1585\u20131594 (2015).","journal-title":"Am. J. Clin. Nutr."},{"key":"72057_CR6","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/ajh.24820","volume":"92","author":"MD Cappellini","year":"2017","unstructured":"Cappellini, M. D. et al. Iron deficiency across chronic inflammatory conditions: international expert opinion on definition, diagnosis, and management. Am. J. Hematol. 92, 1068\u20131078 (2017).","journal-title":"Am. J. Hematol."},{"key":"72057_CR7","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJM199109053251004","volume":"325","author":"B Lozoff","year":"1991","unstructured":"Lozoff, B., Jimenez, E. & Wolf, A. W. Long-term developmental outcome of infants with iron deficiency. N. Engl. J. Med. 325, 687\u2013694 (1991).","journal-title":"N. Engl. J. Med."},{"key":"72057_CR8","doi-asserted-by":"publisher","first-page":"1588S","DOI":"10.3945\/ajcn.117.155846","volume":"106","author":"MK Georgieff","year":"2017","unstructured":"Georgieff, M. K. Iron assessment to protect the developing brain. Am. J. Clin. Nutr. 106, 1588S-1593S (2017).","journal-title":"Am. J. Clin. Nutr."},{"key":"72057_CR9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.acvd.2014.07.049","volume":"107","author":"A Cohen-Solal","year":"2014","unstructured":"Cohen-Solal, A. et al. Diagnosis and treatment of iron deficiency in patients with heart failure: expert position paper from French cardiologists. Arch. Cardiovasc. Dis. 107, 563\u2013571 (2014).","journal-title":"Arch. Cardiovasc. Dis."},{"key":"72057_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","volume":"165","author":"IT Klip","year":"2013","unstructured":"Klip, I. T. et al. Iron deficiency in chronic heart failure: an international pooled analysis. Am. Heart J. 165, 575\u2013582 (2013).","journal-title":"Am. Heart J."},{"key":"72057_CR11","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ijcard.2017.04.110","volume":"243","author":"P Moliner","year":"2017","unstructured":"Moliner, P. et al. Clinical correlates and prognostic impact of impaired iron storage versus impaired iron transport in an international cohort of 1821 patients with chronic heart failure. Int. J. Cardiol. 243, 360\u2013366 (2017).","journal-title":"Int. J. Cardiol."},{"key":"72057_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bja.2019.09.016","volume":"124","author":"J Rossler","year":"2020","unstructured":"Rossler, J. et al. Iron deficiency is associated with higher mortality in patients undergoing cardiac surgery: a prospective study. Br. J. Anaesth. 124, 25\u201334 (2020).","journal-title":"Br. J. Anaesth."},{"key":"72057_CR13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1161\/CIRCULATIONAHA.106.653501","volume":"116","author":"A Kulier","year":"2007","unstructured":"Kulier, A. et al. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation 116, 471\u2013479 (2007).","journal-title":"Circulation"},{"key":"72057_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/ALN.0b013e3182054d06","volume":"114","author":"LG Glance","year":"2011","unstructured":"Glance, L. G. et al. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology 114, 283\u2013292 (2011).","journal-title":"Anesthesiology"},{"key":"72057_CR15","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1515\/cclm-2012-0129","volume":"50","author":"S Ferraro","year":"2012","unstructured":"Ferraro, S., Mozzi, R. & Panteghini, M. Revaluating serum ferritin as a marker of body iron stores in the traceability era. Clin. Chem. Lab. Med. 50, 1911\u20131916 (2012).","journal-title":"Clin. Chem. Lab. Med."},{"key":"72057_CR16","first-page":"9394060","volume":"2018","author":"A Dignass","year":"2018","unstructured":"Dignass, A., Farrag, K. & Stein, J. Limitations of serum ferritin in diagnosing iron deficiency in inflammatory conditions. Int. J. Chronic Dis. 2018, 9394060 (2018).","journal-title":"Int. J. Chronic Dis."},{"key":"72057_CR17","first-page":"639","volume":"73","author":"H Le Petitcorps","year":"2015","unstructured":"Le Petitcorps, H., Monti, A. & Pautas, E. Iron deficiency in elderly patients: use of biomarkers. Ann. Biol. Clin. (Paris). 73, 639\u2013642 (2015).","journal-title":"Ann. Biol. Clin. (Paris)."},{"key":"72057_CR18","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1111\/hdi.12543","volume":"21","author":"AL Langer","year":"2017","unstructured":"Langer, A. L. & Ginzburg, Y. Z. Role of hepcidin-ferroportin axis in the pathophysiology, diagnosis, and treatment of anemia of chronic inflammation. Hemodial. Int. 21, S37\u2013S46 (2017).","journal-title":"Hemodial. Int."},{"key":"72057_CR19","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/ejhf.1305","volume":"20","author":"T McDonagh","year":"2018","unstructured":"McDonagh, T. et al. Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice. Eur. J. Heart Fail. 20, 1664\u20131672 (2018).","journal-title":"Eur. J. Heart Fail."},{"key":"72057_CR20","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/ejhf.837","volume":"19","author":"LNL Van Aelst","year":"2017","unstructured":"Van Aelst, L. N. L. et al. Iron status and inflammatory biomarkers in patients with acutely decompensated heart failure: early in-hospital phase and 30-day follow-up. Eur. J. Heart Fail. 19, 1075\u20131076 (2017).","journal-title":"Eur. J. Heart Fail."},{"key":"72057_CR21","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/apt.14922","volume":"48","author":"L Peyrin-Biroulet","year":"2018","unstructured":"Peyrin-Biroulet, L. et al. Review article: treating-to-target for inflammatory bowel disease-associated anaemia. Aliment Pharmacol. Ther. 48, 610\u2013617 (2018).","journal-title":"Aliment Pharmacol. Ther."},{"key":"72057_CR22","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3390\/nu10091173","volume":"10","author":"N Ueda","year":"2018","unstructured":"Ueda, N. & Takasawa, K. Impact of inflammation on ferritin, hepcidin and the management of iron deficiency anemia in chronic kidney disease. Nutrients. 10, 1173 (2018).","journal-title":"Nutrients."},{"key":"72057_CR23","unstructured":"French National Authority for Health (Haute Autorit\u00e9 de Sant\u00e9, France). Choix des examens du m\u00e9tabolisme du fer en cas de suspicion de carence en fer - rapport d\u2019\u00e9valuation. https:\/\/www.has-sante.fr\/portail\/jcms\/c_1051506\/fr\/choix-des-examens-du-metabolisme-du-fer-en-cas-de-suspicion-de-carence-en-fer-rapport-d-evaluation (2011)."},{"key":"72057_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3917\/pos.403.0213","volume":"40","author":"L de Roquefeuil","year":"2009","unstructured":"de Roquefeuil, L., Studer, A., Neumann, A. & Merli\u00e8re, V. L\u2019\u00e9chantillon g\u00e9n\u00e9raliste de b\u00e9n\u00e9ficiaires\u202f: repr\u00e9sentativit\u00e9, port\u00e9e et limites. Pratiques et Organisation des Soins. 40, 213\u2013223 (2009).","journal-title":"Pratiques et Organisation des Soins."},{"key":"72057_CR25","doi-asserted-by":"publisher","first-page":"e1001885","DOI":"10.1371\/journal.pmed.1001885","volume":"12","author":"E Benchimol","year":"2015","unstructured":"Benchimol, E. et al. The reporting of studies conducted using observational routinely-collected health data (RECORD) Statement. PLoS Med. 12, e1001885 (2015).","journal-title":"PLoS Med."},{"key":"72057_CR26","doi-asserted-by":"crossref","first-page":"359S","DOI":"10.3945\/ajcn.116.141762","volume":"106","author":"SM Namaste","year":"2017","unstructured":"Namaste, S. M. et al. Adjusting ferritin concentrations for inflammation: biomarkers reflecting inflammation and nutritional determinants of anemia (BRINDA) project. Am. J. Clin. Nutr. 106, 359S-371S (2017).","journal-title":"Am. J. Clin. Nutr."},{"key":"72057_CR27","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1093\/clinchem\/47.10.1804","volume":"47","author":"JA Koziol","year":"2001","unstructured":"Koziol, J. A., Ho, N. J., Felitti, V. J. & Beutler, E. Reference centiles for serum ferritin and percentage of transferrin saturation, with application to mutations of the HFE gene. Clin. Chem. 47, 1804\u20131810 (2001).","journal-title":"Clin. Chem."},{"key":"72057_CR28","doi-asserted-by":"crossref","unstructured":"Heath, A.L., Fairweather-Tait, S., Worwood, M. Reference limits for haemoglobin and ferritin. If it\u2019s not broken, don\u2019t fix it. BMJ. 323, 806-807 (2001).","DOI":"10.1136\/bmj.323.7316.806"},{"key":"72057_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cgh.2013.07.019","volume":"12","author":"EJ McKinnon","year":"2014","unstructured":"McKinnon, E. J., Rossi, E., Beilby, J. P., Trinder, D. & Olynyk, J. K. Factors that affect serum levels of ferritin in Australian adults and implications for follow-up. Clin. Gastroenterol. Hepatol. 12, 101\u2013108 (2014).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"72057_CR30","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2016.12.034","volume":"168","author":"MU Muckenthaler","year":"2017","unstructured":"Muckenthaler, M. U., Rivella, S., Hentze, M. W. & Galy, B. A red carpet for iron metabolism. Cell 168, 344\u2013361 (2017).","journal-title":"Cell"},{"key":"72057_CR31","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00277-020-03906-w","volume":"99","author":"G Russo","year":"2020","unstructured":"Russo, G. et al. Monitoring oral iron therapy in children with iron deficiency anemia: an observational, prospective, multicenter study of AIEOP patients (Associazione Italiana Emato-Oncologia Pediatrica). Ann. Hematol. 99, 413\u2013420 (2020).","journal-title":"Ann. Hematol."},{"key":"72057_CR32","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0140-6736(15)60865-0","volume":"387","author":"A Lopez","year":"2016","unstructured":"Lopez, A., Cacoub, P., Macdougall, I. C. & Peyrin-Biroulet, L. Iron deficiency anaemia. Lancet 387, 907\u2013916 (2016).","journal-title":"Lancet"},{"key":"72057_CR33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/MPH.0b013e3182588996","volume":"34","author":"E Parodi","year":"2012","unstructured":"Parodi, E. et al. Reticulocyte parameters: markers of early response to oral treatment in children with severe iron-deficiency anemia. J. Pediatr. Hematol. Oncol. 34, 249\u2013252 (2012).","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"72057_CR34","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.2215\/CJN.01490506","volume":"1","author":"JB Wish","year":"2006","unstructured":"Wish, J. B. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin. J. Am. Soc. Nephrol. 1, S4-8 (2006).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"72057_CR35","unstructured":"World Health Organisation. Serum Ferritin Concentrations for the Assessment of Iron Status and Iron Deficiency in Populations. https:\/\/www.who.int\/vmnis\/indicators\/ferritin\/en\/. (2011)."},{"key":"72057_CR36","doi-asserted-by":"publisher","first-page":"e0202460","DOI":"10.1371\/journal.pone.0202460","volume":"13","author":"A Mahalhal","year":"2018","unstructured":"Mahalhal, A. et al. Oral iron exacerbates colitis and influences the intestinal microbiome. PLoS ONE 13, e0202460 (2018).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72057-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72057-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72057-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T06:29:09Z","timestamp":1696660149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72057-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["72057"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-72057-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,11]]},"assertion":[{"value":"6 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Patrice Cacoub has received consulting and lecturing fees from Abbvie, AstraZeneca, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Janssen, Merck Sharp & Dohme, Servier, and Vifor. Katell Peoc'h has received consulting and lecturing fees from France, Fresenius, Kabi, Masimo, Octapharma, Werfen, Vifor, Siemens Healthineers, Abbott, Brahms, Diasorin and research grants from MSD Avenir and Fujirebio. Ga\u00ebl Nicolas has declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14983"}}